EconPapers    
Economics at your fingertips  
 

Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 COVID-19 Vaccines among Mobile Phone Users in Malawi: Findings from a National Mobile-Based Syndromic Surveillance Survey, July 2021 to December 2021

Lucky Makonokaya (), Lester Kapanda, Godfrey B. Woelk, Annie Chauma-Mwale, Louiser Upile Kalitera, Harrid Nkhoma, Suzgo Zimba, Rachel Chamanga, Cathy Golowa, Rhoderick Machekano and Thulani Maphosa
Additional contact information
Lucky Makonokaya: Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi
Lester Kapanda: Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi
Godfrey B. Woelk: Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC 20005, USA
Annie Chauma-Mwale: Public Health Institute, Ministry of Health Malawi, Lilongwe P.O. Box 30377, Malawi
Louiser Upile Kalitera: Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi
Harrid Nkhoma: Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi
Suzgo Zimba: Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi
Rachel Chamanga: Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi
Cathy Golowa: Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi
Rhoderick Machekano: Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC 20005, USA
Thulani Maphosa: Elizabeth Glaser Pediatric AIDS Foundation, Lilongwe P/Bag 2543, Malawi

IJERPH, 2023, vol. 20, issue 23, 1-12

Abstract: The safety profiles of the Ad26.COV2.S and AZD1222 COVID-19 vaccines have not been described in the general population in Malawi. We present self-reported adverse events (AE) following the receipt of these vaccines in Malawi as part of a national syndromic surveillance survey. We conducted phone-based syndromic surveillance surveys among adults (≥18 years) with verbal consent. We used secure tablets through random digit dialing to select mobile phone numbers and collected data electronically. Survey questions included whether the respondent had received the COVID-19 vaccines, whether they had experienced any AE following vaccination, and the severity of the AE. We used multivariable analysis to identify factors associated with self-reported AE post-COVID-19 vaccination. A total of 11,924 (36.0%) out of 33,150 respondents reported receiving at least one dose of either Ad26.COV2.S or AZD1222 between July–December 2021; of those, 65.1% were female. About 49.2% of the vaccine recipients reported at least one AE, 90.6% of which were mild, and 2.6% were severe. Higher education level and concern about the safety of COVID-19 vaccines were associated with AE self-report (Adjusted Odds Ratio [AOR] 2.63 [95% CI 1.96–3.53] and 1.44, [95% CI 1.30–1.61], respectively), while male gender and older age were associated with reduced likelihood of AE self-report (AORs 0.81, [95% CI 0.75–0.88], 0.62 [95% CI 0.50–0.77], respectively). Ad26.COV2.S and AZD1222 vaccines are well-tolerated, with primarily mild and few severe AE among adults living in Malawi. Self-reporting of AE following COVID-19 vaccination is associated with gender, age, education, and concern about the safety of the vaccines. Recognizing these associations is key when designing and implementing COVID-19 vaccination communication messages to increase vaccination coverage.

Keywords: COVID-19; SARS-CoV-2; adverse events; Ad26.COV2.S; AZD1222; Malawi; mobile phone-based syndromic surveillance survey; vaccination; self-report (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2023
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/20/23/7123/pdf (application/pdf)
https://www.mdpi.com/1660-4601/20/23/7123/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:20:y:2023:i:23:p:7123-:d:1291497

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().

 
Page updated 2025-03-19
Handle: RePEc:gam:jijerp:v:20:y:2023:i:23:p:7123-:d:1291497